The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

Sponsors and Collaborators
Tina Vilsboll
Novo Nordisk
Rigshospitalet, Denmark

Contact
Signe Foghsgaard, MD
+4539772058
[email protected]

Louise Vedtofte, M.Sc., PhD
+4539772688
[email protected]


Continue Reading

Principal Investigator
Tina Vilsbøll, MD, DMSc, University Hospital Gentofte

ClinicalTrials.gov Identifier
NCT01795248